Navigation Links
Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
Date:5/29/2008

COLUMBIA, Md. and INDIANAPOLIS, May 29 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC and Martek Biosciences Corporation today announced a collaborative agreement to jointly develop and commercialize a canola seed that produces the omega-3 fatty acid, DHA (docosahexaenoic acid).

Under the terms of the agreement, Martek and Dow AgroSciences will co-develop the canola seed, which will produce a DHA-rich canola oil that will be part of Dow AgroSciences' "next generation" of food industry oils. The intent of the collaboration is to develop a DHA-rich canola oil which would strengthen Martek's position as a leading producer and marketer of DHA-enriched oils and powders and complement Dow AgroSciences' current Omega-9 Oils platform which is being widely adopted by the food industry to remove trans fat and reduce saturated fat in food products. Dow AgroSciences and Martek anticipate a multi-year effort to produce this new healthy oil, which when commercialized will be marketed to the food industry.

DHA omega-3 is a long-chain fatty acid that serves as the primary structural fatty acid found in the brain and the eyes, and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in the diet. Scientific reviews highlight the importance of DHA omega-3 in proper brain and eye development and function, and clinical studies are underway to evaluate the role of DHA in decreasing the prevalence of certain neurological disorders. Yet despite its importance, Americans have among the lowest dietary intakes of DHA omega-3 in the world.

Today DHA is primarily sourced from algal fermentation and fish oil. Production of DHA in canola will allow for a more cost-effective vegetarian supply for use in certain food applications.

"Nutritionists are now recommending that people increase their consumption of DHA, as most consumers don't get enough in their diets today," said Daniel R. Kittle, Ph.D., global R&D leader and vice president, Dow AgroSciences. "Martek, with its strong portfolio in omega-3 fatty acids, will be a great addition to the continued development of our rapidly growing canola and sunflower Healthy Oils platform."

"As the leading innovator in DHA science and technology, Martek is pleased to partner with agricultural leader Dow AgroSciences, to combine our unique technologies and intellectual property for the creation of an oilseed source of DHA, a nutrient that is important to human health throughout the lifecycle," said Steve Dubin, Martek CEO. "Dow AgroSciences' expertise and commitment to healthy nutritional solutions complements Martek's own values and strengths, making this an ideal collaboration."

Financial terms of the agreement were not disclosed.

About Dow AgroSciences

Dow AgroSciences LLC (NYSE: DOW), based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $3.8 billion. Learn more at http://www.dowagro.com. To learn about Omega-9 Oils go to http://www.dowagro.com/omega9oils/.

About Martek Biosciences Corporation

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also markets life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com/. For a complete listing of life'sDHA products, visit http://www.lifesdha.com/.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2007 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

For More Information:

Robyn Heine

Dow AgroSciences

317-337-4807

Cassie France-Kelly

Martek Biosciences

410-740-0081


'/>"/>
SOURCE Martek Biosciences Corporation; Dow AgroSciences LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
2. Martek to Announce Third Quarter 2007 Results on September 5, 2007
3. Martek to Present at Upcoming UBS Conference
4. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
5. Martek Announces Settlement of OmegaTech Milestone Litigation
6. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
7. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
8. Martek to Present at Upcoming ThinkEquity Partners Conference
9. Martek Announces Fourth Quarter and FY 2007 Financial Results
10. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
11. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
Breaking Biology News(10 mins):